1. Home
  2. AVDL vs ARRY Comparison

AVDL vs ARRY Comparison

Compare AVDL & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • ARRY
  • Stock Information
  • Founded
  • AVDL 2015
  • ARRY 1989
  • Country
  • AVDL Ireland
  • ARRY United States
  • Employees
  • AVDL N/A
  • ARRY N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • ARRY Semiconductors
  • Sector
  • AVDL Health Care
  • ARRY Technology
  • Exchange
  • AVDL Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • AVDL 784.6M
  • ARRY 649.7M
  • IPO Year
  • AVDL 1996
  • ARRY 2020
  • Fundamental
  • Price
  • AVDL $9.46
  • ARRY $5.82
  • Analyst Decision
  • AVDL Strong Buy
  • ARRY Buy
  • Analyst Count
  • AVDL 7
  • ARRY 21
  • Target Price
  • AVDL $18.86
  • ARRY $9.84
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • ARRY 5.5M
  • Earning Date
  • AVDL 05-07-2025
  • ARRY 05-06-2025
  • Dividend Yield
  • AVDL N/A
  • ARRY N/A
  • EPS Growth
  • AVDL N/A
  • ARRY N/A
  • EPS
  • AVDL N/A
  • ARRY N/A
  • Revenue
  • AVDL $194,450,000.00
  • ARRY $1,064,767,000.00
  • Revenue This Year
  • AVDL $50.53
  • ARRY $21.75
  • Revenue Next Year
  • AVDL $32.33
  • ARRY $11.66
  • P/E Ratio
  • AVDL N/A
  • ARRY N/A
  • Revenue Growth
  • AVDL 252.64
  • ARRY N/A
  • 52 Week Low
  • AVDL $6.38
  • ARRY $3.76
  • 52 Week High
  • AVDL $17.85
  • ARRY $14.85
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.93
  • ARRY 60.28
  • Support Level
  • AVDL $8.55
  • ARRY $4.92
  • Resistance Level
  • AVDL $9.98
  • ARRY $5.92
  • Average True Range (ATR)
  • AVDL 0.50
  • ARRY 0.40
  • MACD
  • AVDL 0.11
  • ARRY 0.13
  • Stochastic Oscillator
  • AVDL 77.73
  • ARRY 78.81

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: